Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06630117
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-03
Brief Title:
A Study of V330 in Healthy Younger 18 to 49 Years Inclusive and Healthy Older 60 to 79 Years Inclusive Participants V330-001
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Randomized Double-Blind Placebo-Controlled Dose Escalation Trial to Evaluate the Safety Tolerability and Immunogenicity of V330 in Healthy Younger 18 to 49 Years Inclusive and Healthy Older Participants 60 to 79 Years Inclusive
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to learn whether a new vaccine V330 is safe and learn how well the bodys immune system responds by making antibodies after receiving V330
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None